Extending the lymphoblastoid cell line model for drug combination pharmacogenomics

This work was supported by R01CA161608 from the National Cancer Institute and by intramural funds from the National Institute of Environmental Health Sciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

留言 (0)

沒有登入
gif